These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17205778)

  • 41. Inactivation of TNF signaling by rationally designed dominant-negative TNF variants.
    Steed PM; Tansey MG; Zalevsky J; Zhukovsky EA; Desjarlais JR; Szymkowski DE; Abbott C; Carmichael D; Chan C; Cherry L; Cheung P; Chirino AJ; Chung HH; Doberstein SK; Eivazi A; Filikov AV; Gao SX; Hubert RS; Hwang M; Hyun L; Kashi S; Kim A; Kim E; Kung J; Martinez SP; Muchhal US; Nguyen DH; O'Brien C; O'Keefe D; Singer K; Vafa O; Vielmetter J; Yoder SC; Dahiyat BI
    Science; 2003 Sep; 301(5641):1895-8. PubMed ID: 14512626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Ectodysplasin and NFkappaB signalling pathways in odontogenesis.
    Courtney JM; Blackburn J; Sharpe PT
    Arch Oral Biol; 2005 Feb; 50(2):159-63. PubMed ID: 15721144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced expressions of endometrial tumour necrosis factor alpha and its receptors during early pregnancy in bonnet monkeys.
    Rosario GX; Sachdeva G; Manjramkar DD; Puri CP
    Cytokine; 2005 Sep; 31(6):459-64. PubMed ID: 16112585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor necrosis factor family ligand-receptor binding.
    Zhang G
    Curr Opin Struct Biol; 2004 Apr; 14(2):154-60. PubMed ID: 15093829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restoration of membrane TNF-like activity by cell surface targeting and matrix metalloproteinase-mediated processing of a TNF prodrug.
    Gerspach J; Müller D; Münkel S; Selchow O; Nemeth J; Noack M; Petrul H; Menrad A; Wajant H; Pfizenmaier K
    Cell Death Differ; 2006 Feb; 13(2):273-84. PubMed ID: 16052236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biology of tumor necrosis factor-alpha- implications for psoriasis.
    Schottelius AJ; Moldawer LL; Dinarello CA; Asadullah K; Sterry W; Edwards CK
    Exp Dermatol; 2004 Apr; 13(4):193-222. PubMed ID: 15086336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms.
    Grivennikov SI; Kuprash DV; Liu ZG; Nedospasov SA
    Int Rev Cytol; 2006; 252():129-61. PubMed ID: 16984817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of tumor necrosis factor alpha and its receptors during cellular differentiation.
    Schling P; Rudolph C; Heimerl S; Fruth S; Schmitz G
    Cytokine; 2006 Mar; 33(5):239-45. PubMed ID: 16580225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of membrane-bound tumor necrosis factor (TNF): an analysis of TNF-specific reagents.
    Gerspach J; Götz A; Zimmermann G; Kolle C; Böttinger H; Grell M
    Microsc Res Tech; 2000 Aug; 50(3):243-50. PubMed ID: 10891890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Signalling pathways of the TNF superfamily: a double-edged sword.
    Aggarwal BB
    Nat Rev Immunol; 2003 Sep; 3(9):745-56. PubMed ID: 12949498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Signal transduction by tumor necrosis factor and its relatives.
    Baud V; Karin M
    Trends Cell Biol; 2001 Sep; 11(9):372-7. PubMed ID: 11514191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis.
    Caulin C; Ware CF; Magin TM; Oshima RG
    J Cell Biol; 2000 Apr; 149(1):17-22. PubMed ID: 10747083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of human tumour necrosis factor receptor 1 dominant-negative mutants reveals a major region controlling cell surface expression.
    Fielding CA; Siebert S; Rowe M; Brennan P
    FEBS Lett; 2004 Jul; 570(1-3):138-42. PubMed ID: 15251454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival and apoptotic pathways initiated by TNF-alpha: modeling and predictions.
    Rangamani P; Sirovich L
    Biotechnol Bioeng; 2007 Aug; 97(5):1216-29. PubMed ID: 17171720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor necrosis factor signaling.
    Wajant H; Pfizenmaier K; Scheurich P
    Cell Death Differ; 2003 Jan; 10(1):45-65. PubMed ID: 12655295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The evaluation of tumor necrosis factor-alpha concentration in body fluids in local and systemic endotoxin exposure].
    Kretzschmar C
    Zentralbl Veterinarmed B; 1996 Nov; 43(9):525-38. PubMed ID: 9045542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aspirin, TNF-alpha, NFkB, and survival in multiple myeloma: the importance of measuring TNF-alpha.
    Kast RE
    Inflammopharmacology; 2006 Dec; 14(5-6):256-9. PubMed ID: 17139447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system.
    Eissner G; Kolch W; Scheurich P
    Cytokine Growth Factor Rev; 2004 Oct; 15(5):353-66. PubMed ID: 15450251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural basis of signal transduction in the TNF receptor superfamily.
    Li J; Yin Q; Wu H
    Adv Immunol; 2013; 119():135-53. PubMed ID: 23886067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gatekeeper mechanisms for immature B cells.
    Sun XH; Kincade PW
    Nat Immunol; 2002 Oct; 3(10):898-9. PubMed ID: 12352965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.